Electra City Tower
58 Harakevet St.
Tel Aviv
6777016
Rahaf Awawdi
Rahaf is an associate in the firm’s Corporate Department.
Adv. Rahaf Awawdi advises on corporate and commercial law, with a particular focus on investment and merger and acquisition transactions in high-tech companies.
Rahaf provides legal advice to companies in connection with their day-to-day operations and ongoing corporate and commercial needs.
She represents public and private companies operating in the technology sector, as well as leading funds and investors.
Rahaf interned at Barnea Jaffa Lande.
Education:
Haifa University, LL.B., 2020
Admission:
Israel Bar Association, 2023
Insights & News - Rahaf Awawdi :
Inven Capital Co-Leads Wint’s Funding Round
We are proud to have advised Inven Capital, which co-led Wint’s funding round. Wint develops technology for the early detection of water waste and the prevention of costly water damage. Adv. Ariella Dreyfuss and Adv. Rahaf Awawdi of our firm advised Inven Capital throughout the transaction.
Singapore-Based Prytek Acquires TipRanks at USD 200 Million Valuation
Adv. Ariella Dreyfuss and Adv. Rahaf Awawdi represented TipRanks in a transaction in which Prytek acquired an additional 40% stake in TipTanks, becoming its controlling shareholder. In 2021, TipRanks raised USD 77 million, partially through a secondary offering led by Prytek. This transaction was also handled by the firm, with Adv. Hanna Daher assisting in all tax aspects.
Barnea: Representing Thermo Fisher in Investment in CytoReason
Our firm represented Thermo Fisher in its participation in CytoReason's USD 80 million financing round, alongside notable investors OurCrowd, Nvidia, and Pfizer. CytoReason provides pharmaceutical and therapeutic leaders with molecular-level insights and advanced AI tools that support data-driven decision-making in healthcare and the life sciences. Adv. Simon Jaffa, Adv. Ariella Dreyfuss, and Adv. Rahaf Awawdi represented Thermo Fisher in the transaction.